Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Orthofix Medical (OFIX) Change in Receivables (2016 - 2026)

Orthofix Medical has reported Change in Receivables over the past 16 years, most recently at $3.0 million for Q1 2026.

For the quarter ending Q1 2026, Change in Receivables rose 224.59% year-over-year to $3.0 million, compared with a TTM value of $6.9 million through Mar 2026, down 12.99%, and an annual FY2025 reading of $1.6 million, down 83.38% over the prior year.
Change in Receivables came in at $3.0 million for Q1 2026, down from $4.7 million in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $13.3 million in Q4 2023 to a low of -$5.4 million in Q1 2022.
Median Change in Receivables over the past 5 years was $103000.0 (2024), compared with a mean of $1.8 million.
The sharpest move saw Change in Receivables skyrocketed 1143.63% in 2023, then crashed 2731.07% in 2025.
Over 5 years, Change in Receivables stood at $6.8 million in 2022, then skyrocketed by 96.33% to $13.3 million in 2023, then dropped by 18.73% to $10.8 million in 2024, then plummeted by 56.46% to $4.7 million in 2025, then plummeted by 37.12% to $3.0 million in 2026.
Per Business Quant, the three most recent readings for OFIX's Change in Receivables are $3.0 million (Q1 2026), $4.7 million (Q4 2025), and $2.0 million (Q3 2025).